CEL-SCI
CVM----
CEL-SCI (CVM)
CEL-SCI Corporation, a clinical-stage biotechnology company, engages in the research and development to treat cancer and other diseases by using the immune syst...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
CEL-SCI Analyst Rating
View MoreForecast & Rating
Jul 20, 2026Price forecast
$15.001171.19%
Forecast & RatingBuy
1analysts
- Strong buy0.00%
- Buy100.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- PUBT · Jul 20 at 08:58 AM
First Berlin reiterates Buy on CEL-SCI, cuts price target to USD 15
- PUBT · Jul 13 at 07:01 AM
CEL-SCI notifies availability of Multikine Phase 3 confirmatory study launch release
- PUBT · Jul 2 at 04:03 PM
CEL-SCI announces annual shareholder meeting
- PUBT · Jun 24 at 07:01 AM
CEL-SCI signs agreement with Saudi Amarox to support Multikine commercialization in Saudi Arabia
- TradingView · Jun 16 at 04:13 PM
CEL-SCI Completes $2.5M Stock Offering at $1.00, Engages ThinkEquity as Placement Agent
- StockTitan · Jun 14 at 10:03 AM
CEL-SCI Corporation Announces Pricing of Offering | CVM Stock News
